Company news

Medipal Holdings Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Notice Regarding Partial Amendments to the Articles of Incorporation

November 5, 2026

Notice Regarding Holding of an Extraordinary General Meeting of Shareholders and Opinion of the Company’s Board of Directors on Shareholder Proposal

November 5, 2026

Initiatives for Medium- to Long-Term Enhancement of Corporate Value

November 5, 2026

Consolidated Financial Statements for the Second Quarter (Interim Period) of the Fiscal Year Ending March 31, 2027

November 5, 2026

Notice Regarding Shareholder’s Petition for Permission to Convene an Extraordinary General Meeting of Shareholders

October 26, 2026

Notice Regarding Revision of Full-Year Consolidated Financial Forecasts

October 23, 2026

Notice Regarding Recording of Gain on Sale of Investment Securities (Extraordinary Income)

October 23, 2026

Notice Regarding Decision on Matters Concerning Acquisition of Treasury Stock and Cancellation of Treasury Stock

October 23, 2026

Notice Regarding Setting of Record Date for Convocation of an Extraordinary General Meeting of Shareholders

October 13, 2026

Notice Regarding Changes of Representative Directors and Directors

September 8, 2026

Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2027

August 5, 2026

Notice Regarding Revision of Full-Year Consolidated Financial Forecasts

July 14, 2026

Notice Regarding Results of the Tender Offer for Shares of PALTAC CORPORATION (Securities Code: 8283)

July 8, 2026

Medipal Holdings: Consolidated Financial Statements for the Fiscal Year Ended March 31, 2026

May 14, 2026

Notice Regarding Dividends of Retained Earnings (Dividend Increase)

May 14, 2026

Notice of Investment in Metagen Therapeutics, Inc. through MEDIPAL Innovation Fund

February 25, 2026

(Update on Disclosed Matter) Notice Regarding the Completion of MP AGRO CO., LTD.'s Acquisition of Cygni Holdings, Inc. Shares

January 30, 2026

Notice Regarding Results and Completion of Acquisition of Treasury Stock and Number of Cancellation Shares of Treasury Stock

November 5, 2025

Notice Regarding Business Transfer of Consolidated Subsidiary

October 28, 2025

Notice Regarding MP AGRO CO., LTD.'s Acquisition of All Shares of Cygni Holdings, Inc.

October 9, 2025

Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by Ministry of Health, Labour and Welfare of Japan

September 29, 2025

MEDIPAL HOLDINGS and JCR Pharmaceuticals Sign Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Therapy for GM2 Gangliosidosis

September 2, 2025

Notice Regarding Progress of Acquisition of Treasury Stock

August 4, 2025

Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by European Commission (EC)

June 24, 2025

Notice of Acquisition of Shares of PHARUMO, Inc.

June 10, 2025

Notice of Completion of MEDICEO “Medical Distribution Center Kobe”

May 27, 2025

Notice of Transfer of Representative Director (Additional Selection) and Acting President

May 23, 2025

Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by the U.S. FDA

May 7, 2025

Decks

The 5 newest of 68 decks. Every deck is listed under its year.